Jw Holdings (096760) - Total Assets
Based on the latest financial reports, Jw Holdings (096760) holds total assets worth ₩1.23 Trillion KRW (≈ $833.08 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Jw Holdings shareholders equity for net asset value and shareholders' equity analysis.
Jw Holdings - Total Assets Trend (2007–2024)
This chart illustrates how Jw Holdings's total assets have evolved over time, based on quarterly financial data.
Jw Holdings - Asset Composition Analysis
Current Asset Composition (December 2024)
Jw Holdings's total assets of ₩1.23 Trillion consist of 33.7% current assets and 66.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 3.5% |
| Accounts Receivable | ₩162.38 Billion | 13.0% |
| Inventory | ₩161.59 Billion | 12.9% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩73.47 Billion | 5.9% |
| Goodwill | ₩153.17 Billion | 12.3% |
Asset Composition Trend (2007–2024)
This chart illustrates how Jw Holdings's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 096760 market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jw Holdings's current assets represent 33.7% of total assets in 2024, an increase from 0.0% in 2007.
- Cash Position: Cash and equivalents constituted 3.5% of total assets in 2024, up from 2.8% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 12.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 13.0% of total assets.
Jw Holdings Competitors by Total Assets
Key competitors of Jw Holdings based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.34 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥15.32 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
Jw Holdings - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.88 | 0.82 | 0.76 |
| Quick Ratio | 0.54 | 0.57 | 0.51 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩-55.46 Billion | ₩-108.73 Billion | ₩-146.83 Billion |
Jw Holdings - Advanced Valuation Insights
This section examines the relationship between Jw Holdings's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.15 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 6.3% |
| Total Assets | ₩1.25 Trillion |
| Market Capitalization | $200.69 Million USD |
Valuation Analysis
Below Book Valuation: The market values Jw Holdings's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Jw Holdings's assets grew by 6.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Jw Holdings (2007–2024)
The table below shows the annual total assets of Jw Holdings from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩1.25 Trillion ≈ $847.52 Million |
+6.32% |
| 2023-12-31 | ₩1.18 Trillion ≈ $797.14 Million |
+1.61% |
| 2022-12-31 | ₩1.16 Trillion ≈ $784.48 Million |
+8.61% |
| 2021-12-31 | ₩1.07 Trillion ≈ $722.26 Million |
-4.73% |
| 2020-12-31 | ₩1.12 Trillion ≈ $758.15 Million |
-10.03% |
| 2019-12-31 | ₩1.24 Trillion ≈ $842.68 Million |
-2.52% |
| 2018-12-31 | ₩1.28 Trillion ≈ $864.48 Million |
-5.60% |
| 2017-12-31 | ₩1.35 Trillion ≈ $915.81 Million |
+12.93% |
| 2016-12-31 | ₩1.20 Trillion ≈ $810.94 Million |
+10.51% |
| 2015-12-31 | ₩1.08 Trillion ≈ $733.84 Million |
+4.52% |
| 2014-12-31 | ₩1.04 Trillion ≈ $702.09 Million |
+2.13% |
| 2013-12-31 | ₩1.01 Trillion ≈ $687.47 Million |
-5.82% |
| 2012-12-31 | ₩1.08 Trillion ≈ $729.96 Million |
-1.61% |
| 2011-12-31 | ₩1.09 Trillion ≈ $741.92 Million |
+48.57% |
| 2010-12-31 | ₩736.86 Billion ≈ $499.36 Million |
+3.84% |
| 2009-12-31 | ₩709.64 Billion ≈ $480.91 Million |
+10.52% |
| 2008-12-31 | ₩642.09 Billion ≈ $435.13 Million |
+15.71% |
| 2007-12-31 | ₩554.89 Billion ≈ $376.04 Million |
-- |
About Jw Holdings
JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair … Read more